000088520 001__ 88520
000088520 005__ 20210902121626.0
000088520 0247_ $$2doi$$a10.1186/s12902-019-0468-y
000088520 0248_ $$2sideral$$a117208
000088520 037__ $$aART-2020-117208
000088520 041__ $$aeng
000088520 100__ $$aKivelä, J.
000088520 245__ $$aObtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes- A narrative literature review
000088520 260__ $$c2020
000088520 5060_ $$aAccess copy available to the general public$$fUnrestricted
000088520 5203_ $$aBackground: Feel4Diabetes was a school and community based intervention aiming to promote healthy lifestyle and tackle obesity for the prevention of type 2 diabetes among families in 6 European countries. We conducted this literature review in order to guide the development of evidence-based implementation of the Feel4Diabetes intervention. We focused on type 2 diabetes prevention strategies, including all the phases from risk identification to implementation and maintenance. Special focus was given to prevention among vulnerable groups and people under 45 years. Methods: Scientific and grey literature published between January 2000 and January 2015 was searched for relevant studies using electronic databases. To present the literature review findings in a systematic way, we used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. A complementary literature search from February 2015 to December 2018 was also conducted. Results: The initial review included 27 studies with a follow-up =12 months and 9 studies with a follow-up =6 months and with a participant mean age < 45 years. We found out that interventions should be targeted at people at risk to improve recruiting and intervention effectiveness. Screening questionnaires (primarily Finnish Diabetes Risk Score FINDRISC) and blood glucose measurement can both be used for screening; the method does not appear to affect intervention effectiveness. Screening and recruitment is time-consuming, especially when targeting lower socioeconomic status and age under 45 years. The intervention intensity is more important for effectiveness than the mode of delivery. Moderate changes in several lifestyle habits lead to good intervention results. A minimum of 3-year follow-up seemed to be required to show a reduction in diabetes risk in high-risk individuals. In participants < 45 years, the achieved results in outcomes were less pronounced. The complementary review included 12 studies, with similar results regarding intervention targets and delivery modes, as well as clinical significance. Conclusion: This narrative review highlighted several important aspects that subsequently guided the development of the Feel4Diabetes high-risk intervention. Research on diabetes prevention interventions targeted at younger adults or vulnerable population groups is still relatively scarce. Feel4Diabetes is a good example of a project aiming to fill this research gap.
000088520 536__ $$9info:eu-repo/grantAgreement/EC/H2020/643708/EU/Developing and implementing a community-based intervention to create a more supportive social and physical environment for lifestyle changes to prevent diabetes in vulnerable families across Europe/Feel4Diabetes$$9This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 643708-Feel4Diabetes
000088520 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000088520 590__ $$a2.763$$b2020
000088520 591__ $$aENDOCRINOLOGY & METABOLISM$$b110 / 145 = 0.759$$c2020$$dQ4$$eT3
000088520 592__ $$a0.743$$b2020
000088520 593__ $$aMedicine (miscellaneous)$$c2020$$dQ2
000088520 593__ $$aEndocrinology, Diabetes and Metabolism$$c2020$$dQ2
000088520 655_4 $$ainfo:eu-repo/semantics/review$$vinfo:eu-repo/semantics/publishedVersion
000088520 700__ $$aWikström, K.
000088520 700__ $$aVirtanen, E.
000088520 700__ $$aGeorgoulis, M.
000088520 700__ $$aCardon, G.
000088520 700__ $$0(orcid)0000-0001-7043-0952$$aCiveira, F.$$uUniversidad de Zaragoza
000088520 700__ $$aIotova, V.
000088520 700__ $$aKaruranga, E.
000088520 700__ $$aKo, W.
000088520 700__ $$aLiatis, S.
000088520 700__ $$aMakrilakis, K.
000088520 700__ $$aManios, Y.
000088520 700__ $$0(orcid)0000-0001-6650-8294$$aMateo-Gallego, R.$$uUniversidad de Zaragoza
000088520 700__ $$aNanasi, A.
000088520 700__ $$aRurik, I.
000088520 700__ $$aTankova, T.
000088520 700__ $$aTsochev, K.
000088520 700__ $$aVan Stappen, V.
000088520 700__ $$aLindström, J.
000088520 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería
000088520 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000088520 773__ $$g20, Supl 1 (2020), 140 [24 pp.]$$pBMC ENDOCRINE DISORDERS$$tBMC endocrine disorders$$x1472-6823
000088520 8564_ $$s943816$$uhttps://zaguan.unizar.es/record/88520/files/texto_completo.pdf$$yVersión publicada
000088520 8564_ $$s48380$$uhttps://zaguan.unizar.es/record/88520/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000088520 909CO $$ooai:zaguan.unizar.es:88520$$particulos$$pdriver
000088520 951__ $$a2021-09-02-08:50:34
000088520 980__ $$aARTICLE